Neuroleptic rechallenge after neuroleptic malignant syndrome.
Giacardi-Paty
M
M
Bottai
T
T
Pujalte
D
D
Lainey
E
E
Petit
P
P
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D009460:Neurologic Examination / Q000187:drug effects; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012008:Recurrence; D012307:Risk Factors
D014150:Antipsychotic Agents; D003024:Clozapine